General Information of the Compound
| Compound ID |
CP0430098
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(1R)-2-(1H-indol-3-yl)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]-2-[3-(trifluoromethyl)phenyl]acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H23F3N4O
|
||||||||||||||||||
| Molecular Weight |
488.513
|
||||||||||||||||||
| Canonical SMILES |
FC(F)(F)c1cccc(CC(=O)N[C@H](Cc2c[nH]c3ccccc23)c2nc(c[nH]2)-c2ccccc2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H23F3N4O/c29-28(30,31)21-10-6-7-18(13-21)14-26(36)34-24(15-20-16-32-23-12-5-4-11-22(20)23)27-33-17-25(35-27)19-8-2-1-3-9-19/h1-13,16-17,24,32H,14-15H2,(H,33,35)(H,34,36)/t24-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VADSOILOUXGLQQ-XMMPIXPASA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00930, Somatostatin receptor type 1
Protein ID: PT01505, Somatostatin receptor type 2
Protein ID: PT01693, Somatostatin receptor type 3
Protein ID: PT01398, Somatostatin receptor type 4
Protein ID: PT01196, Somatostatin receptor type 5